Atlas Trials

Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease

Clinical trial NCT00101946 · COMPLETED

Trial details

NCT number
NCT00101946
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2004-10-01
Primary completion
2006-07-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.